SkyView Investment Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97K | Buy |
10,766
+266
| +3% | +$2.4K | 0.01% | 270 |
|
|
2025
Q1 | $79K | Sell |
10,500
-2,500
| -19% | -$18.8K | 0.01% | 267 |
|
|
2024
Q4 | $98K | Hold |
13,000
| – | – | 0.02% | 240 |
|
|
2024
Q3 | $99K | Buy |
13,000
+3,000
| +30% | +$22.8K | 0.02% | 238 |
|
|
2024
Q2 | $62K | Hold |
10,000
| – | – | 0.01% | 280 |
|
|
2024
Q1 | $51K | Buy |
+10,000
| New | +$51K | 0.01% | 266 |
|